Core Viewpoint - The Hong Kong stock market has seen a continuous share buyback trend since 2026, with leading companies like Yidu Tech (02158) actively participating to demonstrate confidence in their intrinsic value and future development [1] Group 1: Share Buyback Activity - Yidu Tech announced a share buyback on February 16, repurchasing 404,000 shares at approximately HKD 5.91 per share, totaling nearly HKD 2.4 million [1] - This marks the 15th buyback since the beginning of 2026, with a cumulative expenditure of nearly HKD 67 million [1] - The buyback activity has been characterized by high frequency and steady intensity, with 15 buybacks completed in less than a month since the first buyback on January 26 [1] Group 2: Business Developments - Yidu Tech's recent collaboration with Huazhong University of Science and Technology's Tongji Hospital on a multimodal AI database project for gastrointestinal tumors has been selected for the Ministry of Industry and Information Technology's 2025 AI medical device innovation initiative [1] - The company's growth prospects have been recognized by institutions, with Citigroup maintaining a "Buy" rating and raising the target price to HKD 11 in February [1]
港股龙头回购持续发力，医渡科技(02158)一月内15次回购，机构看好其AI医疗布局